BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 24559928)

  • 1. Role of the mammalian target of rapamycin (mTOR) complexes in pancreatic β-cell mass regulation.
    Bartolome A; Guillén C
    Vitam Horm; 2014; 95():425-69. PubMed ID: 24559928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Kinase-Dead mTOR Impairs Glucose Homeostasis by Regulating Insulin Secretion and Not β-Cell Mass.
    Alejandro EU; Bozadjieva N; Blandino-Rosano M; Wasan MA; Elghazi L; Vadrevu S; Satin L; Bernal-Mizrachi E
    Diabetes; 2017 Aug; 66(8):2150-2162. PubMed ID: 28546423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
    Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
    J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes.
    Yuan T; Rafizadeh S; Gorrepati KD; Lupse B; Oberholzer J; Maedler K; Ardestani A
    Diabetologia; 2017 Apr; 60(4):668-678. PubMed ID: 28004151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTORC2 Signaling: A Path for Pancreatic β Cell's Growth and Function.
    Yuan T; Lupse B; Maedler K; Ardestani A
    J Mol Biol; 2018 Mar; 430(7):904-918. PubMed ID: 29481838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mTORC2/PKC pathway sustains compensatory insulin secretion of pancreatic β cells in response to metabolic stress.
    Xie Y; Cui C; Nie A; Wang Y; Ni Q; Liu Y; Yin Q; Zhang H; Li Y; Wang Q; Gu Y; Ning G
    Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):2039-2047. PubMed ID: 28435021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cannabinoid CB1 receptor and mTORC1 signalling pathways interact to modulate glucose homeostasis in mice.
    Bermudez-Silva FJ; Romero-Zerbo SY; Haissaguerre M; Ruz-Maldonado I; Lhamyani S; El Bekay R; Tabarin A; Marsicano G; Cota D
    Dis Model Mech; 2016 Jan; 9(1):51-61. PubMed ID: 26563389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy and pancreatic β-cells.
    Mazza S; Maffucci T
    Vitam Horm; 2014; 95():145-64. PubMed ID: 24559917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAD-A and AMPK kinases: the "yin and yang" regulators of mTORC1 signaling in pancreatic β cells.
    Nie J; Han X; Shi Y
    Cell Cycle; 2013 Nov; 12(21):3366-9. PubMed ID: 24047693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC1 and mTORC2 Complexes Regulate the Untargeted Metabolomics and Amino Acid Metabolites Profile through Mitochondrial Bioenergetic Functions in Pancreatic Beta Cells.
    Soliman GA; Abzalimov RR; He Y
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.
    Yoon MS
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKCζ Is Essential for Pancreatic β-Cell Replication During Insulin Resistance by Regulating mTOR and Cyclin-D2.
    Lakshmipathi J; Alvarez-Perez JC; Rosselot C; Casinelli GP; Stamateris RE; Rausell-Palamos F; O'Donnell CP; Vasavada RC; Scott DK; Alonso LC; Garcia-Ocaña A
    Diabetes; 2016 May; 65(5):1283-96. PubMed ID: 26868297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-site binding inhibitor effectively targets mTORC1 and mTORC2 complexes in glioblastoma.
    Neil J; Shannon C; Mohan A; Laurent D; Murali R; Jhanwar-Uniyal M
    Int J Oncol; 2016 Mar; 48(3):1045-52. PubMed ID: 26719046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTORC1 pathway mediates beta cell compensatory proliferation in 60 % partial-pancreatectomy mice.
    Li W; Zhang H; Nie A; Ni Q; Li F; Ning G; Li X; Gu Y; Wang Q
    Endocrine; 2016 Jul; 53(1):117-28. PubMed ID: 26818915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenic role of persistent milk signaling in mTORC1- and milk-microRNA-driven type 2 diabetes mellitus.
    Melnik BC
    Curr Diabetes Rev; 2015; 11(1):46-62. PubMed ID: 25587719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic modeling of signal transduction by mTOR complexes in cancer.
    Dorvash M; Farahmandnia M; Mosaddeghi P; Farahmandnejad M; Saber H; Khorraminejad-Shirazi M; Azadi A; Tavassoly I
    J Theor Biol; 2019 Dec; 483():109992. PubMed ID: 31493485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles for the mTOR pathway in postnatal morphogenesis, maturation and function of pancreatic islets.
    Sinagoga KL; Stone WJ; Schiesser JV; Schweitzer JI; Sampson L; Zheng Y; Wells JM
    Development; 2017 Jul; 144(13):2402-2414. PubMed ID: 28576773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic mTOR: the rookie energy sensor.
    Martínez de Morentin PB; Martinez-Sanchez N; Roa J; Ferno J; Nogueiras R; Tena-Sempere M; Dieguez C; Lopez M
    Curr Mol Med; 2014 Jan; 14(1):3-21. PubMed ID: 24236459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrient signaling to mTOR and cell growth.
    Jewell JL; Guan KL
    Trends Biochem Sci; 2013 May; 38(5):233-42. PubMed ID: 23465396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.